Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

John Bimba

Biographic Data

ID9066249
NAMEJohn Bimba
GIVEN NAMESJohn
FAMILY NAMEBimba
SIGNATUREBIMBA J
AFFILIATIONSBingham University
ORCID0000-0001-7847-4271
VERIFIEDYes
TOTAL WORKS5
TOTAL CITATIONS0
AUTHOR COUNT5
EDITOR COUNT0
FIRST PUBLICATION YEAR2022
LATEST PUBLICATION YEAR2026
H-INDEX0
  • Acceptability of Covid-19 self-testing among social and clinical vulnerable populations using a decentralized testing model in Abuja, Nigeria; A mixed methods analysis of an implementation study

    Open Access•Elvis Isere, John Bimba et al.•ARTICLE•PLOS Global Public Health•2026

    Diagnostic testing is critical during infectious disease outbreaks, enabling timely patient management and isolation to reduce transmission and mortality. During the COVID-19 outbreak in Nigeria, testing rates remained low due to limited access to centralized RT-PCR sites. To expand access, the National COVID-19 Testing Strategy (January 2021) introduced decentralized self-testing models targeting vulnerable populations. This study assessed the u…

  • Provider costs of professional Covid-19 rapid antigen testing in low-income settings

    Open Access•Collin Mangenah, Lucky G Ngwira et al.•ARTICLE•PLOS Global Public Health•2025

    World Health Organization recommends antigen rapid diagnostic tests (RDT) as point of care tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in suspected outbreaks when polymerase-chain-reaction testing is not accessible; to trace the extent of outbreaks; and in areas with widespread community transmission. Annual economic costs were estimated for professional SARS-CoV-2 testing as part of several COVID-19 testing use cases i…

  • Understanding the acceptability of Covid-19 antigen rapid diagnostic tests

    Open Access•Wezzie Lora, Wezzie S Lora et al.•ARTICLE•PLOS Global Public Health•2025

    Accessible and timely diagnostic testing was essential during the COVID-19 pandemic to control the virus’s spread and mitigate severe outcomes. However, real-time polymerase chain reaction tests, although sensitive incur high costs and prolonged turnaround times, and face implementation challenges in many resource-constrained settings. Antigen rapid diagnostic tests (Ag-RDT), which can be administered either by providers or as self-tests, are acc…

  • Performance evaluation of Sars-CoV-2 rapid diagnostic tests in Nigeria

    Open Access•Akhere A Omonkhua, Adedayo Omotayo FANEYE et al.•ARTICLE•PLOS Global Public Health•2024

    The COVID-19 pandemic challenged health systems globally. Reverse transcription polymerase chain reaction (RT-PCR) is the gold standard for detecting the presence of SARS-CoV-2 in clinical samples. Rapid diagnostic test (RDT) kits for COVID-19 have been widely used in Nigeria. This has greatly improved test turnover rates and significantly decreased the high technical demands of RT-PCR. However, there is currently no nationally representative eva…

  • Engaging pharmacies in tuberculosis control

    Open Access•Jacob Bigio, Nathaly Aquilera Vasquez et al.•ARTICLE•BMJ Global Health•2022

No prominent works on this page.

  • Engaging pharmacies in tuberculosis control

    Open Access•Jacob Bigio, Nathaly Aquilera Vasquez et al.•ARTICLE•BMJ Global Health•2022

  • Performance evaluation of Sars-CoV-2 rapid diagnostic tests in Nigeria

    Open Access•Akhere A Omonkhua, Adedayo Omotayo FANEYE et al.•ARTICLE•PLOS Global Public Health•2024

    The COVID-19 pandemic challenged health systems globally. Reverse transcription polymerase chain reaction (RT-PCR) is the gold standard for detecting the presence of SARS-CoV-2 in clinical samples. Rapid diagnostic test (RDT) kits for COVID-19 have been widely used in Nigeria. This has greatly improved test turnover rates and significantly decreased the high technical demands of RT-PCR. However, there is currently no nationally representative eva…

  • Provider costs of professional Covid-19 rapid antigen testing in low-income settings

    Open Access•Collin Mangenah, Lucky G Ngwira et al.•ARTICLE•PLOS Global Public Health•2025

    World Health Organization recommends antigen rapid diagnostic tests (RDT) as point of care tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in suspected outbreaks when polymerase-chain-reaction testing is not accessible; to trace the extent of outbreaks; and in areas with widespread community transmission. Annual economic costs were estimated for professional SARS-CoV-2 testing as part of several COVID-19 testing use cases i…

  • Understanding the acceptability of Covid-19 antigen rapid diagnostic tests

    Open Access•Wezzie Lora, Wezzie S Lora et al.•ARTICLE•PLOS Global Public Health•2025

    Accessible and timely diagnostic testing was essential during the COVID-19 pandemic to control the virus’s spread and mitigate severe outcomes. However, real-time polymerase chain reaction tests, although sensitive incur high costs and prolonged turnaround times, and face implementation challenges in many resource-constrained settings. Antigen rapid diagnostic tests (Ag-RDT), which can be administered either by providers or as self-tests, are acc…

  • Acceptability of Covid-19 self-testing among social and clinical vulnerable populations using a decentralized testing model in Abuja, Nigeria; A mixed methods analysis of an implementation study

    Open Access•Elvis Isere, John Bimba et al.•ARTICLE•PLOS Global Public Health•2026

    Diagnostic testing is critical during infectious disease outbreaks, enabling timely patient management and isolation to reduce transmission and mortality. During the COVID-19 outbreak in Nigeria, testing rates remained low due to limited access to centralized RT-PCR sites. To expand access, the National COVID-19 Testing Strategy (January 2021) introduced decentralized self-testing models targeting vulnerable populations. This study assessed the u…

SARS-CoV-2 and COVID-19 Research (4 works) · SARS-CoV-2 detection and testing (4 works) · Diagnostic test (3 works) · COVID-19 Clinical Research Studies (2 works) · Health care (2 works) · Medicine (2 works) · Outbreak (2 works) · Test strategy (2 works) · Antibiotic Use and Resistance (1 works) · Biosensors and Analytical Detection (1 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae